Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Semaglutide, and other GLP-1 drugs like it, have experienced shortages in the past two years as millions of Americans have turned to the medications for help with significant weight loss. While ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

Since then, the company has fallen behind in the weight-loss drug race against competitors like Eli Lilly and Novo Nordisk. A ...

SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...

See Also GLP-1s masterfully reduce the amount of inflammation in the body by stimulating weight loss, interacting with immune ...

Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.

According to SAHPRA, GLP-1-containing products, like Ozempic, which help lower blood sugar levels and promote weight loss, ...

Unicef's representative in Pakistan issued a stark warning about the severe health risks posed by hazardous air quality in Punjab, impacting over 11 million children. The alarming pollution levels ...